Sernova Biotherapeutics Inc (TSX:SVA)
Canada · Delayed Price · Currency is CAD 0.1600
-0.0050 (-3.03%)
Oct 27, 2025, 2:17 PM EDT
Sernova Biotherapeutics Employees
Sernova Biotherapeutics had 17 employees as of October 31, 2024.
Employees
17
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-1.42M CAD
Market Cap
65.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
Sernova Biotherapeutics News
- 26 days ago - Sernova converts $13.3M debt to equity ahead of clinical milestone - Seeking Alpha
- 26 days ago - Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang - Newsfile Corp
- 4 weeks ago - Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors - TheNewswire
- 7 weeks ago - Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference - TheNewswire
- 3 months ago - Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - GlobeNewsWire
- 5 months ago - Sernova Appoints Jonathan Rigby as Interim Chair - GlobeNewsWire
- 5 months ago - Chair of Sernova Biotherapeutics Resigns - GlobeNewsWire
- 5 months ago - Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes - GlobeNewsWire